Guided Therapeutics Total Debt vs. Debt To Equity
| GTHP Stock | USD 0.18 0.01 5.88% |
For Guided Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guided Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guided Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guided Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guided Therapeutics over time as well as its relative position and ranking within its peers.
Guided |
Guided Therapeutics Debt To Equity vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Guided Therapeutics's current stock value. Our valuation model uses many indicators to compare Guided Therapeutics value to that of its competitors to determine the firm's financial worth. Guided Therapeutics is rated as one of the top companies in total debt category among its peers. It also is one of the top stocks in debt to equity category among its peers . The ratio of Total Debt to Debt To Equity for Guided Therapeutics is about 2,390,000 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guided Therapeutics' earnings, one of the primary drivers of an investment's value.Guided Total Debt vs. Competition
Guided Therapeutics is rated as one of the top companies in total debt category among its peers. Total debt of Medical Devices industry is currently estimated at about 18.13 Million. Guided Therapeutics holds roughly 1.43 Million in total debt claiming about 8% of all equities under Medical Devices industry.
Guided Debt To Equity vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Guided Therapeutics |
| = | 1.43 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Guided Therapeutics |
| = | 0.60 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Guided Debt To Equity Comparison
Guided Therapeutics is currently under evaluation in debt to equity category among its peers.
Guided Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Guided Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Guided Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Guided Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Guided Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. Guided Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 5 people.
Guided Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Guided Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Guided Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Guided Therapeutics' important profitability drivers and their relationship over time.
Use Guided Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guided Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will appreciate offsetting losses from the drop in the long position's value.Guided Therapeutics Pair Trading
Guided Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Guided Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guided Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guided Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guided Therapeutics to buy it.
The correlation of Guided Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guided Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guided Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guided Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Guided Therapeutics position
In addition to having Guided Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tips ETFs Thematic Idea Now
Tips ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Tips ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tips ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Guided OTC Stock Analysis
When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.